The Patent Trial and Appeal Board has now given rulings in all 33 petitions filed by Kyle Bass’s Coalition for Affordable Drugs. The final tally is that the coalition succeeded in getting claims invalidated in 27% of the total petitions filed and 50% of those that were instituted
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
IPH's Canadian acquisitions are paying off on paper, but a couple of strong years may not be enough to show that the group's strategy has truly won over the market
Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia